KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Total Current Liabilities (2018 - 2025)

BioNTech SE's Total Current Liabilities history spans 8 years, with the latest figure at $2.5 billion for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 7.51% to $2.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 billion, a 7.51% decrease, with the full-year FY2025 number at $2.4 billion, down 10.23% from a year prior.
  • Total Current Liabilities hit $2.5 billion in Q4 2025 for BioNTech SE, down from $2.6 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for BNTX hit a ceiling of $5.8 billion in Q3 2021 and a floor of $1.6 billion in Q1 2021.
  • Historically, Total Current Liabilities has averaged $2.9 billion across 5 years, with a median of $2.6 billion in 2025.
  • Biggest five-year swings in Total Current Liabilities: soared 1743.58% in 2021 and later plummeted 61.52% in 2023.
  • Tracing BNTX's Total Current Liabilities over 5 years: stood at $4.0 billion in 2021, then fell by 24.42% to $3.0 billion in 2022, then decreased by 26.0% to $2.2 billion in 2023, then grew by 21.03% to $2.7 billion in 2024, then fell by 7.51% to $2.5 billion in 2025.
  • Business Quant data shows Total Current Liabilities for BNTX at $2.5 billion in Q4 2025, $2.6 billion in Q3 2025, and $2.1 billion in Q2 2025.